Ohta, H; Suzuki, S; Ogasawara, K. Studies on Fentanyl and Related Compounds IV. Chromatographic and Spectrometric Discrimination of Fentanyl and its Derivatives. J. Anal. Toxicol., 1 Jul 1999, 23 (4), 280-285. 354 kB. https://doi.org/10.1093/jat/23.4.280 #11
DEA. Temporary Placement of Seven Fentanyl-Related Substances in Schedule I. Federal Register, 1 Feb 2018. #9826
EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #44
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances. In New Psychoactive Substances : Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #4-Chloroisobutyrfentanyl
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology, 1 May 2018, 134 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #4-chloroisobutyrylfentanyl
Anon. INCB: Fentanyl-related substances with no known legitimate use. 24 Jun 2018, n/a. 189 kB. #82
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Sci. Int., 1 Dec 2020, 317 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #4-Cl-isobutyrylfentanyl